Clinical Research in the Lay Press: Irresponsible Journalism Raises a Huge Dose of Doubt
Elias Anaissie(Clinical Trial and Consulting), Richard N. Greenberg(University of Alabama at Birmingham), Hamdi Akan(Ankara University), Jay A. Fishman(Massachusetts General Hospital), John D. Cleary(University of Mississippi Medical Center), Jennifer S. Daly(University of Massachusetts Chan Medical School), María Cecilia Dignani, Howard Belzberg(University of Southern California), David R. Andes(University of Wisconsin–Madison), Danny Benjamin(Duke University), Catherine Cordonnier(Université Paris-Est Créteil), Graeme N. Forrest(University of Maryland, Baltimore), John N. Greene(Moffitt Cancer Center), George L. Drusano(University of Florida), Antonio Arrieta(Children's Hospital of Orange County), William E. Dismukes(University of Alabama), Rhonda Fleming(Texas Tech University), Monica Grazziutti(National Institutes of Health), Ben E. dePauw(Radboud University Nijmegen), Murat Akova(Hacettepe University), Gerald R. Donowitz(University of Virginia), Brahm H. Segal(Roswell Park Comprehensive Cancer Center), Louis de Repentigny(Université de Montréal), Michael Kleinberg(National Institutes of Health), Oliver A. Cornely(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), B. Dupont(Délégation Paris 5), Thomas G. Boyce(Centers for Disease Control and Prevention), John W. Baddley(University of Alabama at Birmingham), Ana Espinel‐Ingroff, J. Peter Donnelly(Baylor College of Medicine), Arturo Casadevall(Johns Hopkins University), Nicholas Daoura(National Institutes of Health), David W. Denning(Manchester Academic Health Science Centre), Elisabeth E. Adderson(St. Jude Children's Research Hospital), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Nikolaos G. Almyroudis(Roswell Park Comprehensive Cancer Center), Mahmoud A. Ghannoum(Case Western Reserve University), Michelle Barron(University of Colorado Denver), John R. Perfect(Duke University), Michael Ellis(University of Illinois Urbana-Champaign), Manuel Cuenca‐Estrella(Instituto de Salud Carlos III), Helen W. Boucher(Tufts Medical Center), Peter G. Pappas(University of Alabama at Birmingham), Mitchell Goldman(Amicus Therapeutics (United States)), Carola Arndt(Mayo Clinic), John R. Graybill(Office of Infectious Diseases), Robert H. Rubin(Massachusetts General Hospital), Felice C. Adler‐Shohet(Children's Hospital of Orange County), P.H. Chandrasekar(Wayne State University), Barbara D. Alexander(Duke University)
Cited by 3
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
|Journal of Fungi|2017|2.9k